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INTRODUCTION: Type 2 Diabetes is due to insulin resistance and it causes various 
metabolic derangements and oxidative stress, which when not controlled could lead to 
fatal complications. In this article we are going to assess such parameters that might 
prevent complications when screened at the earliest. 
OBJECTIVES: To assess the metabolic risk factors and total antioxidant capacity 
that prevents oxidative stress and type 2 Diabetes patients in an Urban setting 
METHODS: 50 Cases and 50 Controls were taken. Both cases and controls were 
measured for Height and Weight and BMI was calculated. Serum samples were used 
for assessing metabolic risk factors which include FBS, PPBS, Lipid profile, HbA1C 
and AIP is calculated. The Total Antioxidant Capacity(TAC) was measured using 
heparinised plasma. Metabolic risk factors mentioned above were done in 
autoanalyzers while TAC was done spectrophotometrically. 
RESULTS: BMI between cases and controls did not show statistically significant 
difference. All other values showed statistical significance. Mean Fasting blood sugar 
and mean HbA1C values between cases and controls were 155.8mg/dL and 8.87%; 
81.96mg/dL and 5.61% respectively. The mean TGL and Total Cholesterol of Cases 
and Controls are 262.89mg/dL and 241.34mg/dL; 101.56mg/dL and 155.09mg/dL 
respectively. Mean HDL and AIP values for cases and controls are 22.62mg/dL and -
0.09; 55.77mg/dL and +5.32 respectively. That TAC values for cases and controls are 
0.65 and 1.49 respectively.  
CONCLUSION: The results shows significantly increased metabolic risk factors and 
reduced TAC values between cases and controls which might proceed to different 
complications in Diabetes which include Chronic Kidney Disease, Diabetic 
Retinopathy, even Atherosclerosis. Therefore these values could be assessed just after 
diagnosing Type 2 Diabetes and taken for screening of complications in T2DM 
patients.   
 
